This beaten-down biotech stock is a cure for your portfolio
August 09, 2016 at 05:08 AM EDT
If you only ever buy shares of one biotech company, Gilead Sciences is the one and now is the time, writes Michael Brush.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.